 | Up a level |
Geidl-Flueck, Bettina; Hochuli, Michel; Spinas, Giatgen A; Gerber, Philipp A (2022). Do Sugar-Sweetened Beverages Increase Fasting FGF21 Irrespective of the Type of Added Sugar? A Secondary Exploratory Analysis of a Randomized Controlled Trial. Nutrients, 14(19) Molecular Diversity Preservation International MDPI 10.3390/nu14194169
Geidl-Flueck, Bettina; Hochuli, Michel; Németh, Ágota; Eberl, Anita; Derron, Nina; Köfeler, Harald C; Tappy, Luc; Berneis, Kaspar; Spinas, Giatgen A; Gerber, Philipp A (2021). Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial. Journal of hepatology, 75(1), pp. 46-54. Elsevier 10.1016/j.jhep.2021.02.027
Kaiser, Nathalie; Gautschi, Matthias; Bosanska, Lenka; Meienberg, Fabian; Baumgartner, Matthias R; Spinas, Giatgen A; Hochuli, Michel (2019). Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry. Molecular genetics and metabolism, 126(4), pp. 355-361. Elsevier 10.1016/j.ymgme.2019.02.008
Wiesli, Peter; Uthoff, Heiko; Perren, Aurel; Pfammatter, Thomas; Zwimpfer, Cornelia; Seiler, Heidi; Kindhauser, René; Spinas, Giatgen A; Schmid, Christoph (2011). Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas? Pancreas, 40(7), pp. 995-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MPA.0b013e31821ffce1
Rizzo, Manfredi; Christ, Emanuel R; Rini, Giovam Battista; Spinas, Giatgen A; Berneis, Kaspar (2008). The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Expert opinion on pharmacotherapy, 9(13), pp. 2295-303. London: Informa Healthcare 10.1517/14656560802321903
